{"contentid": 488613, "importid": NaN, "name": "Genentech\u00e2\u0080\u0099s Swati Tole named CMO at Capsida", "introduction": "Capsida Biotherapeutics, a US biotech creating a new class of targeted gene therapies using its adeno-associated virus (AAV) engineering and cargo development platform, has named Swati Tole as the company\u00e2\u0080\u0099s first chief medical officer.", "content": "<p>Capsida Biotherapeutics, a US biotech creating a new class of targeted gene therapies using its adeno-associated virus (AAV) engineering and cargo development platform, has named Swati Tole (pictured) as the company&rsquo;s first chief medical officer.</p>\n<p>The appointment has been announced just two weeks after Capsida emerged from stealth mode with $140 million of capital, including $90 million from AbbVie (NYSE: ABBV), as part of a multi-year strategic collaboration and option agreement.</p>\n<p>Dr Tole brings extensive drug development experience including senior-level leadership positions in the biotech industry across a wide spectrum of disease areas including rheumatology, gastroenterology, hepatology, and infectious diseases.</p>\n<h2>'Ground-breaking gene therapies'</h2>\n<p>She joins from the Roche (ROG: SIX) unit Genentech, where she spent 13 years in roles of increasing responsibility, most recently as vice president of clinical development. In this position, Dr Tole oversaw and advised teams working on several molecules across the gastroenterology and hepatology spaces.</p>\n<p>Robert Cuddihy, chief executive of Capsida, said: &ldquo;It is with great pleasure that we welcome Swati to our team.</p>\n<p>&ldquo;She has an impressive and highly relevant track record in biologics and small molecule drug development which complements the existing team. Her deep clinical, scientific, and strategic expertise will be instrumental as we execute on our strategy of using our high-throughput AAV engineering platform to create a pipeline of ground-breaking gene therapies across a range of therapeutic areas for indications that are unreachable with current technologies, with initial focus on the central nervous system.&rdquo;</p>\n<h2>'Transformative company'</h2>\n<p>Dr Tole said: &ldquo;I&rsquo;m thrilled to join Capsida and to be a part of the growth of such a transformative company. Capsida&rsquo;s AAV platform, with its differentiated capsids and cargos, has the potential to solve many of the challenges in the field today.&rdquo;</p>\n<p>Capsida has also named the neuroscientist Rita Balice-Gordon to the board of directors. She has served as the chief scientific officer of Muna Therapeutics, a privately-held Danish biotech company focused on developing new therapeutics for neurodegenerative diseases, since May 2020, and has been an entrepreneur-in-residence at the life sciences investor Novo Seeds since August 2020.</p>", "date": "2021-05-12 18:00:00", "meta_title": NaN, "meta_keywords": NaN, "meta_description": NaN, "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-05-12 17:08:29", "updated": "2021-05-12 19:43:44", "access": NaN, "url": "https://www.thepharmaletter.com/article/genentech-s-swati-tole-named-cmo-at-capsida", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "swati_tole_large.jpg", "image2id": "swati_tole_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Cell and Gene Therapy, CNS Diseases, Neurological", "topic_tag": "Boardroom, Management", "geography_tag": "USA", "company_tag": "AbbVie, Capsida, Genentech, Roche", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-05-12 18:00:00"}